Mankind Pharma partnered with Denovo Sciences for AI-led drug discovery.
The Story
This collaboration aims to use artificial intelligence in the process of finding new drugs.
Why It Matters
An established Indian pharmaceutical company investing in AI for drug discovery isn't just about headline innovation. For European CROs and small biotech, this creates direct competitive pressure to evaluate AI tools for their own R&D pipelines. In my experience, vendors will promise miracles; focus on governed execution with your existing data, not a new shiny object. Compliance with the EU AI Act for high-risk applications like drug discovery also needs early planning.
What To Do About It
Review your current R&D data infrastructure. Can your internal datasets be readily accessed and used by an AI model, even a simple one? Before buying new software, check if your Microsoft 365 Copilot subscription can assist with initial data analysis or literature review.
Sources
Related Signals
Nature published a cautionary tale about RAG in clinical practice.
4 Jul 2026
Galux is pushing AI protein design, aiming for bigger global pharma deals by BIO USA 2026. This indicates a clear industry focus on advanced AI applications for drug discovery and development.
29 Jun 2026
Logicboots introduced Coeur.AI at VivaTech Paris 2026. This launch is part of Logicboots' strategy to expand its global footprint through startup accelerators.
28 Jun 2026